title: Correlation between cathepsin D serum concentration and carotid intima-media thickness in hemodialysis patients.
abstract: OBJECTIVE
  Cardiovascular (CV) disease is the leading cause of death in hemodialysis (HD) patients, and approximately half of mortalities in HD patients are attributed to CV disease. Atherosclerosis is the most frequent cause of CV complications in patients with end-stage renal disease (ESRD). Based on recent studies, cathepsin D has been suggested as a potential marker of atherosclerosis, and we hypothesized that there is an association between serum concentration of cathepsin D and carotid intima-media thickness (CIMT) in hemodialysis patients.
  
  
  METHODS
  Thirty-one hemodialysis patients (18 men and 13 women) were enrolled in this study. Serum levels of soluble cathepsin D were measured with an enzyme-linked immunosorbant assay (ELISA) kit. CIMT was determined in each patient.
  
  
  RESULTS
  The data showed that there was a positive significant correlation between serum concentration of cathepsin D and CIMT by using Pearson correlation (P value <0.05).
  
  
  CONCLUSIONS
  Based on the results of this study, cathepsin D could be suggested to have a role in the development of atherosclerotic plaques.
authors.affiliation: Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
authors.forename: Seyed Adel
authors.initials: SA
authors.lastname: Moallem
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Nazemian
authors.forename: Sepideh
authors.initials: S
authors.lastname: Eliasi
authors.forename: Seyed Ali
authors.initials: SA
authors.lastname: Alamdaran
authors.forename: Jamal
authors.initials: J
authors.lastname: Shamsara
authors.forename: Amir Hooshang
authors.initials: AH
authors.lastname: Mohammadpour
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D050197:Atherosclerosis / Q000097:blood* / Q000150:complications* / Q000235:genetics; D015415:Biomarkers / Q000097:blood; D002118:Calcium / Q000097:blood; D059168:Carotid Intima-Media Thickness; D002402:Cathepsin D / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications* / Q000628:therapy; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D006435:Renal Dialysis; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014280:Triglycerides / Q000097:blood; D055815:Young Adult
chemical_list: D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D010281:Parathyroid Hormone; D014280:Triglycerides; D010758:Phosphorus; D002402:Cathepsin D; D002118:Calcium
references.citation: J Atheroscler Thromb. 2008 Aug;15(4):213-8
references.pmid: 18776705
references.citation: Clin Invest Med. 1999 Aug;22(4):149-57
references.pmid: 10497713
references.citation: Clin Sci (Lond). 2004 Oct;107(4):343-54
references.pmid: 15230690
references.citation: Atherosclerosis. 2009 Mar;203(1):112-8
references.pmid: 18715566
references.citation: Circulation. 2007 Jan 30;115(4):459-67
references.pmid: 17242284
references.citation: Circulation. 2000 Jan 4;101(1):E16-22
references.pmid: 10618318
references.citation: Geriatr Gerontol Int. 2008 Sep;8(3):172-9
references.pmid: 18822001
references.citation: Trends Cardiovasc Med. 2007 Jul;17(5):162-71
references.pmid: 17574124
references.citation: Eur J Pharmacol. 2007 May 7;562(1-2):119-29
references.pmid: 17336287
references.citation: Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1359-66
references.pmid: 15178558
references.citation: Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2123-30
references.pmid: 14512372
references.citation: Circulation. 2003 Oct 7;108(14):1664-72
references.pmid: 14530185
references.citation: Am J Pathol. 2002 Sep;161(3):939-45
references.pmid: 12213722
references.citation: Can J Physiol Pharmacol. 2004 Oct;82(10):860-71
references.pmid: 15573146
references.citation: FASEB J. 2007 Oct;21(12):3029-41
references.pmid: 17522380
references.citation: Kidney Int. 1995 Sep;48(3):820-6
references.pmid: 7474670
references.citation: Circulation. 2000 Sep 5;102(10):1186-91
references.pmid: 10973850
references.citation: J Biol Chem. 1994 Nov 18;269(46):29121-8
references.pmid: 7961878
references.citation: Curr Drug Targets. 2002 Apr;3(2):155-73
references.pmid: 11958298
references.citation: J Hypertens. 2002 Feb;20(2):159-69
references.pmid: 11821696
references.citation: Crit Rev Oncol Hematol. 2008 Oct;68(1):12-28
references.pmid: 18396408
references.citation: Nature. 2002 Dec 19-26;420(6917):868-74
references.pmid: 12490960
references.citation: Exp Mol Pathol. 1969 Jun;10(3):288-94
references.pmid: 5788628
references.citation: BMC Cardiovasc Disord. 2006 Oct 26;6:42
references.pmid: 17067397
references.citation: Transplant Proc. 2008 Nov;40(9):3244-6
references.pmid: 19010244
references.citation: Acta Histochem. 2005;107(2):87-93
references.pmid: 15950051
references.citation: Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1430-6
references.pmid: 12750117
references.citation: Ann N Y Acad Sci. 2004 Dec;1030:427-33
references.pmid: 15659826
references.citation: Acta Dermatovenerol Alp Pannonica Adriat. 2006 Dec;15(4):151-7
references.pmid: 17982607
references.citation: Cancer Lett. 1998 Aug 14;130(1-2):49-56
references.pmid: 9751256
references.citation: J Proteome Res. 2005 Jul-Aug;4(4):1181-91
references.pmid: 16083268